APA (7th ed.) Citation

NC, L., LS, C., MC, T., DA, H., CL, W., & CI, L. (2021). Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer. Cancer causes & control : CCC, 32(12), 1375. https://doi.org/10.1007/s10552-021-01485-3

Chicago Style (17th ed.) Citation

NC, Lorona, Cook LS, Tang MC, Hill DA, Wiggins CL, and Li CI. "Antihypertensive Medications and Risks of Recurrence and Mortality in Luminal, Triple-negative, and HER2-overexpressing Breast Cancer." Cancer Causes & Control : CCC 32, no. 12 (2021): 1375. https://doi.org/10.1007/s10552-021-01485-3.

MLA (9th ed.) Citation

NC, Lorona, et al. "Antihypertensive Medications and Risks of Recurrence and Mortality in Luminal, Triple-negative, and HER2-overexpressing Breast Cancer." Cancer Causes & Control : CCC, vol. 32, no. 12, 2021, p. 1375, https://doi.org/10.1007/s10552-021-01485-3.